At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Role of Nicotine Dose and Route of Delivery in Affecting Adoption of E-cigarettes and Reducing Exposure to Toxic Combustion Products
In Brief
A Phase 2 clinical trial evaluating Nicotine patch, Placebo patch, and 2 other interventions for Nicotine Dependence, Cigarettes. Completed, enrolled 94 participants across 1 site.
Detailed Summary
This study plans to investigate whether using electronic cigarettes (e-cigarettes) or skin patches containing nicotine affects switching from smoking conventional combustible (burning) cigarettes.
Study Details
Timeline
Interventions
Participants will wear the nicotine patch daily while switching from cigarette use to use of e-cigarettes for eight weeks.
Participants will wear the placebo patch daily while switching from cigarette use to use of e-cigarettes for eight weeks.
Participants will use e-cigarettes containing nicotine while switching from cigarette use to use of e-cigarettes for eight weeks.
Participants will use e-cigarettes not containing nicotine while switching from cigarette use to use of e-cigarettes for eight weeks.